drugset / Trial / NCT07000994

Dobutamine During Major Abdominal Surgery

NCT07000994

Completed 100 enrolled University of Hamburg-Eppendorf
RandomizedParallel-groupSingle-blindTreatment

Summary

The PUSH-1 trial is a randomized, single-center pilot trial investigating whether dobutamine administration is feasible in patients having major abdominal surgery.

Timeline

Start
2025-06-16
Primary completion
2026-01-28
Completion
2026-02-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Dobutamine Small molecule 3 ug/kg